These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 17663866)

  • 1. [Hypertrophic cardiomyopathy and the implantable cardioverter-defibrillator].
    Manovel-Sánchez AJ; Pedrote-Martínez A; Arana-Rueda E; Errazquin-Sáenz de Tejada F
    Rev Esp Cardiol; 2007 Jul; 60(7):784; author reply 785. PubMed ID: 17663866
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator.
    Maron BJ
    Eur Heart J; 2000 Dec; 21(24):1979-83. PubMed ID: 11102243
    [No Abstract]   [Full Text] [Related]  

  • 3. Implantable cardioverter defibrillators in children.
    Chun TU; Collins KK; Dubin AM
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):561-71. PubMed ID: 15225115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
    Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of an implantable defibrillator for the prevention of sudden death in hypertrophic cardiomyopathy].
    Hentati M; Ben Ameur I; Kechida Z; Charfeddine H; Hached L; Grati Z; Kammoun S
    Tunis Med; 2003; 81 Suppl 8():675-9. PubMed ID: 14608758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sudden death in hypertrophic cardiomyopathy.
    Watkins H
    N Engl J Med; 2000 Feb; 342(6):422-4. PubMed ID: 10666434
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy].
    Maron BJ
    Rev Esp Cardiol; 2006 Jun; 59(6):527-30. PubMed ID: 16790193
    [No Abstract]   [Full Text] [Related]  

  • 8. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Raj SR; Mitchell LB; Sheldon RS
    N Engl J Med; 2000 Jul; 343(1):68-9. PubMed ID: 10896549
    [No Abstract]   [Full Text] [Related]  

  • 9. Transatlantic differences in assessment of risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Jahnlová D; Tomašov P; Zemánek D; Veselka J
    Int J Cardiol; 2015; 186():3-4. PubMed ID: 25804453
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.
    Maron BJ; Estes NA; Maron MS; Almquist AK; Link MS; Udelson JE
    Circulation; 2003 Jun; 107(23):2872-5. PubMed ID: 12814983
    [No Abstract]   [Full Text] [Related]  

  • 11. Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy.
    Cotiga D; Ehlert F; Sherrid M
    Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():55-60. PubMed ID: 17162272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    O'Mahony C; Elliott PM
    Heart; 2014 Feb; 100(3):254-60. PubMed ID: 23574968
    [No Abstract]   [Full Text] [Related]  

  • 13. Implantable defibrillators in hypertrophic cardiomyopathy.
    Grace A
    Heart; 2009 May; 95(9):695-6. PubMed ID: 19282312
    [No Abstract]   [Full Text] [Related]  

  • 14. Can sudden cardiac death be prevented?
    Maron BJ
    Cardiovasc Pathol; 2010; 19(6):329-35. PubMed ID: 20378375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertrophic cardiomyopathy with two episodes of recuperated sudden death. Report of the first implantable defibrillator cardioverter inserted in Chile].
    Zalaquett R; Fajuri A; Irarrázaval MJ; Neghme R; Vergara I; Sacco C; Dubernet J; Corbalán R
    Rev Med Chil; 1994 Oct; 122(10):1171-7. PubMed ID: 7659885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic cardiomyopathy, sudden death, and implantable cardiac defibrillators: how low the bar?
    Nishimura RA; Ommen SR
    JAMA; 2007 Jul; 298(4):452-4. PubMed ID: 17652299
    [No Abstract]   [Full Text] [Related]  

  • 18. [Massive myocardial hypertrophy in hypertrophic cardiomyopathy: a risk factor for sudden death and high defibrillation threshold during cardioverter-defibrillator implantation].
    Jastrzebski M; Czarnecka D; Bacior B; Petkow-Dimitrow P; Wilczek R; Kawecka-Jaszcz K
    Kardiol Pol; 2005 Aug; 63(2):191-5; discussion 196. PubMed ID: 16136416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sudden death as a presenting symptom of hypertrophic cardiomyopathy: treatment with an implantable cardioverter defibrillator.
    Talard P; Lévy S; Bonal J; Paganelli F; Bouchiat C; Cellarier G; Dussarat GV
    Pacing Clin Electrophysiol; 1996 Aug; 19(8):1264-7. PubMed ID: 8865227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Implantable cardioverter defibrillators in pediatric patients: results in a series of 33 cases].
    Tisserant A; Sadoul N; Kouakam C; Kacet S; Rey C; Chauvin M; Lévy J; Mabo P; Marçon F
    Arch Mal Coeur Vaiss; 2006 May; 99(5):433-8. PubMed ID: 16802731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.